Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. / Quaye, L; Song, H; Ramus, S J; Gentry-Maharaj, A; Høgdall, E; DiCioccio, R A; McGuire, V; Wu, A H; Van Den Berg, D J; Pike, M C; Wozniak, E; Doherty, J A; Rossing, M A; Ness, R B; Moysich, K B; Høgdall, C; Blaakaer, J; Ovarian Cancer Association Consortium; Easton, D F; Ponder, B A J; Jacobs, I J; Menon, U; Whittemore, A S; Krüger-Kjaer, S; Pearce, C L; Pharoah, P D P; Gayther, S A.

I: British Journal of Cancer, Bind 100, Nr. 6, 2009, s. 993-1001.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

Quaye, L, Song, H, Ramus, SJ, Gentry-Maharaj, A, Høgdall, E, DiCioccio, RA, McGuire, V, Wu, AH, Van Den Berg, DJ, Pike, MC, Wozniak, E, Doherty, JA, Rossing, MA, Ness, RB, Moysich, KB, Høgdall, C, Blaakaer, J, Ovarian Cancer Association Consortium, Easton, DF, Ponder, BAJ, Jacobs, IJ, Menon, U, Whittemore, AS, Krüger-Kjaer, S, Pearce, CL, Pharoah, PDP & Gayther, SA 2009, 'Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer', British Journal of Cancer, bind 100, nr. 6, s. 993-1001. https://doi.org/10.1038/sj.bjc.6604947

APA

Quaye, L., Song, H., Ramus, S. J., Gentry-Maharaj, A., Høgdall, E., DiCioccio, R. A., ... Gayther, S. A. (2009). Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. British Journal of Cancer, 100(6), 993-1001. https://doi.org/10.1038/sj.bjc.6604947

CBE

Quaye L, Song H, Ramus SJ, Gentry-Maharaj A, Høgdall E, DiCioccio RA, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Wozniak E, Doherty JA, Rossing MA, Ness RB, Moysich KB, Høgdall C, Blaakaer J, Ovarian Cancer Association Consortium, Easton DF, Ponder BAJ, Jacobs IJ, Menon U, Whittemore AS, Krüger-Kjaer S, Pearce CL, Pharoah PDP, Gayther SA. 2009. Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. British Journal of Cancer. 100(6):993-1001. https://doi.org/10.1038/sj.bjc.6604947

MLA

Vancouver

Quaye L, Song H, Ramus SJ, Gentry-Maharaj A, Høgdall E, DiCioccio RA o.a. Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. British Journal of Cancer. 2009;100(6):993-1001. https://doi.org/10.1038/sj.bjc.6604947

Author

Quaye, L ; Song, H ; Ramus, S J ; Gentry-Maharaj, A ; Høgdall, E ; DiCioccio, R A ; McGuire, V ; Wu, A H ; Van Den Berg, D J ; Pike, M C ; Wozniak, E ; Doherty, J A ; Rossing, M A ; Ness, R B ; Moysich, K B ; Høgdall, C ; Blaakaer, J ; Ovarian Cancer Association Consortium ; Easton, D F ; Ponder, B A J ; Jacobs, I J ; Menon, U ; Whittemore, A S ; Krüger-Kjaer, S ; Pearce, C L ; Pharoah, P D P ; Gayther, S A. / Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. I: British Journal of Cancer. 2009 ; Bind 100, Nr. 6. s. 993-1001.

Bibtex

@article{f9126bc003a711dfb95d000ea68e967b,
title = "Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer",
abstract = "Low-moderate risk alleles that are relatively common in the population may explain a significant proportion of the excess familial risk of ovarian cancer (OC) not attributed to highly penetrant genes. In this study, we evaluated the risks of OC associated with common germline variants in five oncogenes (BRAF, ERBB2, KRAS, NMI and PIK3CA) known to be involved in OC development. Thirty-four tagging SNPs in these genes were genotyped in approximately 1800 invasive OC cases and 3000 controls from population-based studies in Denmark, the United Kingdom and the United States. We found no evidence of disease association for SNPs in BRAF, KRAS, ERBB2 and PIK3CA when OC was considered as a single disease phenotype; but after stratification by histological subtype, we found borderline evidence of association for SNPs in KRAS and BRAF with mucinous OC and in ERBB2 and PIK3CA with endometrioid OC. For NMI, we identified a SNP (rs11683487) that was associated with a decreased risk of OC (unadjusted P(dominant)=0.004). We then genotyped rs11683487 in another 1097 cases and 1792 controls from an additional three case-control studies from the United States. The combined odds ratio was 0.89 (95{\%} confidence interval (CI): 0.80-0.99) and remained statistically significant (P(dominant)=0.032). We also identified two haplotypes in ERBB2 associated with an increased OC risk (P(global)=0.034) and a haplotype in BRAF that had a protective effect (P(global)=0.005). In conclusion, these data provide borderline evidence of association for common allelic variation in the NMI with risk of epithelial OC.",
keywords = "1-Phosphatidylinositol 3-Kinase, Adult, Aged, Female, Genes, erbB-2, Genetic Predisposition to Disease, Genotype, Haplotypes, Humans, Intracellular Signaling Peptides and Proteins, Middle Aged, Oncogenes, Ovarian Neoplasms, Polymorphism, Single Nucleotide, Proto-Oncogene Proteins, Proto-Oncogene Proteins B-raf, ras Proteins",
author = "L Quaye and H Song and Ramus, {S J} and A Gentry-Maharaj and E H{\o}gdall and DiCioccio, {R A} and V McGuire and Wu, {A H} and {Van Den Berg}, {D J} and Pike, {M C} and E Wozniak and Doherty, {J A} and Rossing, {M A} and Ness, {R B} and Moysich, {K B} and C H{\o}gdall and J Blaakaer and {Ovarian Cancer Association Consortium} and Easton, {D F} and Ponder, {B A J} and Jacobs, {I J} and U Menon and Whittemore, {A S} and S Kr{\"u}ger-Kjaer and Pearce, {C L} and Pharoah, {P D P} and Gayther, {S A}",
year = "2009",
doi = "10.1038/sj.bjc.6604947",
language = "English",
volume = "100",
pages = "993--1001",
journal = "B J C",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "6",

}

RIS

TY - JOUR

T1 - Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer

AU - Quaye, L

AU - Song, H

AU - Ramus, S J

AU - Gentry-Maharaj, A

AU - Høgdall, E

AU - DiCioccio, R A

AU - McGuire, V

AU - Wu, A H

AU - Van Den Berg, D J

AU - Pike, M C

AU - Wozniak, E

AU - Doherty, J A

AU - Rossing, M A

AU - Ness, R B

AU - Moysich, K B

AU - Høgdall, C

AU - Blaakaer, J

AU - Ovarian Cancer Association Consortium

AU - Easton, D F

AU - Ponder, B A J

AU - Jacobs, I J

AU - Menon, U

AU - Whittemore, A S

AU - Krüger-Kjaer, S

AU - Pearce, C L

AU - Pharoah, P D P

AU - Gayther, S A

PY - 2009

Y1 - 2009

N2 - Low-moderate risk alleles that are relatively common in the population may explain a significant proportion of the excess familial risk of ovarian cancer (OC) not attributed to highly penetrant genes. In this study, we evaluated the risks of OC associated with common germline variants in five oncogenes (BRAF, ERBB2, KRAS, NMI and PIK3CA) known to be involved in OC development. Thirty-four tagging SNPs in these genes were genotyped in approximately 1800 invasive OC cases and 3000 controls from population-based studies in Denmark, the United Kingdom and the United States. We found no evidence of disease association for SNPs in BRAF, KRAS, ERBB2 and PIK3CA when OC was considered as a single disease phenotype; but after stratification by histological subtype, we found borderline evidence of association for SNPs in KRAS and BRAF with mucinous OC and in ERBB2 and PIK3CA with endometrioid OC. For NMI, we identified a SNP (rs11683487) that was associated with a decreased risk of OC (unadjusted P(dominant)=0.004). We then genotyped rs11683487 in another 1097 cases and 1792 controls from an additional three case-control studies from the United States. The combined odds ratio was 0.89 (95% confidence interval (CI): 0.80-0.99) and remained statistically significant (P(dominant)=0.032). We also identified two haplotypes in ERBB2 associated with an increased OC risk (P(global)=0.034) and a haplotype in BRAF that had a protective effect (P(global)=0.005). In conclusion, these data provide borderline evidence of association for common allelic variation in the NMI with risk of epithelial OC.

AB - Low-moderate risk alleles that are relatively common in the population may explain a significant proportion of the excess familial risk of ovarian cancer (OC) not attributed to highly penetrant genes. In this study, we evaluated the risks of OC associated with common germline variants in five oncogenes (BRAF, ERBB2, KRAS, NMI and PIK3CA) known to be involved in OC development. Thirty-four tagging SNPs in these genes were genotyped in approximately 1800 invasive OC cases and 3000 controls from population-based studies in Denmark, the United Kingdom and the United States. We found no evidence of disease association for SNPs in BRAF, KRAS, ERBB2 and PIK3CA when OC was considered as a single disease phenotype; but after stratification by histological subtype, we found borderline evidence of association for SNPs in KRAS and BRAF with mucinous OC and in ERBB2 and PIK3CA with endometrioid OC. For NMI, we identified a SNP (rs11683487) that was associated with a decreased risk of OC (unadjusted P(dominant)=0.004). We then genotyped rs11683487 in another 1097 cases and 1792 controls from an additional three case-control studies from the United States. The combined odds ratio was 0.89 (95% confidence interval (CI): 0.80-0.99) and remained statistically significant (P(dominant)=0.032). We also identified two haplotypes in ERBB2 associated with an increased OC risk (P(global)=0.034) and a haplotype in BRAF that had a protective effect (P(global)=0.005). In conclusion, these data provide borderline evidence of association for common allelic variation in the NMI with risk of epithelial OC.

KW - 1-Phosphatidylinositol 3-Kinase

KW - Adult

KW - Aged

KW - Female

KW - Genes, erbB-2

KW - Genetic Predisposition to Disease

KW - Genotype

KW - Haplotypes

KW - Humans

KW - Intracellular Signaling Peptides and Proteins

KW - Middle Aged

KW - Oncogenes

KW - Ovarian Neoplasms

KW - Polymorphism, Single Nucleotide

KW - Proto-Oncogene Proteins

KW - Proto-Oncogene Proteins B-raf

KW - ras Proteins

U2 - 10.1038/sj.bjc.6604947

DO - 10.1038/sj.bjc.6604947

M3 - Journal article

C2 - 19240718

VL - 100

SP - 993

EP - 1001

JO - B J C

JF - B J C

SN - 0007-0920

IS - 6

ER -